February 28th, 2021
•People with BRCA1 mutations have a higher risk of developing cancer, which warrants accurate evaluation of the function of BRCA1 variants. Herein, we described a protocol for functional assessment of BRCA1 variants using CRISPR-mediated cytosine base editors that enable targeted C:G to T:A conversion in living cells.
Related Videos
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Assessment of the Metabolic Profile of Primary Leukemia Cells
Morphology-Based Distinction Between Healthy and Pathological Cells Utilizing Fourier Transforms and Self-Organizing Maps
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Characterization and Functional Prediction of Bacteria in Ovarian Tissues
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved